ProfileGDS4459 / ENSG00000189164
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 43% 50% 53% 38% 54% 45% 50% 40% 46% 42% 50% 42% 49% 40% 47% 42% 49% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.1943
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.3850
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.5253
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.1138
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.5354
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.2245
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.4350
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.9940
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.2146
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.1242
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.2950
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.0442
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.449
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.0940
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.2247
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.1342
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.3449